![Xian Lin Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xian Lin Li
Président chez China National Pharmaceutical Industry Corp. Ltd.
Fortune : 29 397 $ au 30/06/2024
Provenance du réseau au premier degré de Xian Lin Li
Entité | Type d'entité | Industrie | |
---|---|---|---|
China National Pharmaceutical Industry Corp. Ltd.
![]() China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Xian Lin Li via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Pharmaceuticals: Major | Chairman | |
Qinghai Pharmaceutical (Group) Co., Ltd.
![]() Qinghai Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: OtherHealth Technology Qinghai Pharmaceutical (Group) Co., Ltd. engages in the export of medicines and chemical products. It offers rivanol, hydrochloric acid apomorphine, papaverine hydrochloride, and chemical raw materials. The company was founded on January 17, 2000 and is headquartered in Xining, China. | Pharmaceuticals: Other | Director/Board Member | |
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
Sinopharm Holding Heze Co., Ltd.
![]() Sinopharm Holding Heze Co., Ltd. Financial ConglomeratesFinance Sinopharm Holding Heze Co., Ltd. engages in the sale of Chinese medicines, chemical preparations, and biological products. It also offers medical equipment, dairy products, cosmetics and hygiene products, and biochemical products. Its business activities include domestic advertising, economic and trade consulting, enterprise management, corporate marketing, conference and exhibition services, office equipment leasing, warehousing services, and freight forwarding services. The company was founded on March 7, 2007 and is headquartered in Heze, China. | Financial Conglomerates | Director/Board Member |
Statistiques
Internationale
Chine | 5 |
Sectorielle
Health Technology | 4 |
Finance | 2 |
Opérationnelle
Director/Board Member | 5 |
Director of Finance/CFO | 2 |
Chairman | 1 |
Relations les plus connectées
Insiders | |
---|---|
Hao Li | 4 |
Yu Tao Pan | 2 |
Bao Jun Deng | 1 |
- Bourse
- Insiders
- Xian Lin Li
- Connexions Sociétés